LTT Capital Corp. Announces TSX-V Conditional Approval and Details of Qualifying Transaction with Arura Pharma Inc.

MONTREAL, June 12 /CNW Telbec/ - Further to its preliminary news release of December 19, 2006, LTT Capital Corp. (“LTT”) (TSX V: LTT.P), a Capital Pool Company, in accordance with the policies of the TSX Venture Exchange Inc. (the “TSX-V”), is pleased to announce that the proposed amalgamation of LTT and Arura Pharma Inc. (“Arura”) pursuant to a final agreement dated March 30, 2007 by which LTT will acquire all of the issued and outstanding common shares of Arura (the “Transaction”) received conditional approval from the TSX-V, the Transaction to constitute the qualifying transaction of LTT.

MORE ON THIS TOPIC